Latest Macula of retina Stories
TARRYTOWN, N.Y., Jan. 23, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
HUNTINGTON, N.Y., Jan.
National research foundation awards $1.2 million to scientists conducting groundbreaking research to find a cure for macular degeneration and other retinal diseases CONSHOHOCKEN, Pa., Dec.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
New research from Kantar Health’s National Health and Wellness Survey shows European patients with macular edema are more likely to use insulin and have been diagnosed longer. New
Licensing Agreement Signed For Canadian Market Expected Revenue In Excess Of $30MM USD (PRWEB) October 16, 2014 The Eye Machine, LLC today announced
Easy to use "Oral Strips" Solve Improper Dosing and Pill-Swallowing Issues for Patients Relying on Nutraceuticals to Preserve Ocular Health BIRMINGHAM, Ala., Oct.
SARATOGA, Calif., Oct. 13, 2014 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc.